439 related articles for article (PubMed ID: 19774508)
41. Parthenolide induces apoptosis in glioblastomas without affecting NF-kappaB.
Anderson KN; Bejcek BE
J Pharmacol Sci; 2008 Feb; 106(2):318-20. PubMed ID: 18277052
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of NF-κB and DNA double-strand break repair by DMAPT sensitizes non-small-cell lung cancers to X-rays.
Estabrook NC; Chin-Sinex H; Borgmann AJ; Dhaemers RM; Shapiro RH; Gilley D; Huda N; Crooks P; Sweeney C; Mendonca MS
Free Radic Biol Med; 2011 Dec; 51(12):2249-58. PubMed ID: 22019440
[TBL] [Abstract][Full Text] [Related]
43. Antiproliferative effects of curcuphenol, a sesquiterpene phenol.
Rodrigo G; Almanza GR; Cheng Y; Peng J; Hamann M; Duan RD; Akesson B
Fitoterapia; 2010 Oct; 81(7):762-6. PubMed ID: 20385210
[TBL] [Abstract][Full Text] [Related]
44. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells.
Li Y; Ahmed F; Ali S; Philip PA; Kucuk O; Sarkar FH
Cancer Res; 2005 Aug; 65(15):6934-42. PubMed ID: 16061678
[TBL] [Abstract][Full Text] [Related]
45. PEG-liposomal oxaliplatin combined with nuclear factor-κB inhibitor (PDTC) induces apoptosis in human colorectal cancer cells.
Yang C; Fu ZX
Oncol Rep; 2014 Oct; 32(4):1617-21. PubMed ID: 25174808
[TBL] [Abstract][Full Text] [Related]
46. Suppression of NF-kappaB activity by parthenolide induces X-ray sensitivity through inhibition of split-dose repair in TP53 null prostate cancer cells.
Watson C; Miller DA; Chin-Sinex H; Losch A; Hughes W; Sweeney C; Mendonca MS
Radiat Res; 2009 Apr; 171(4):389-96. PubMed ID: 19397439
[TBL] [Abstract][Full Text] [Related]
47. Atractylenolide III, a sesquiterpenoid, induces apoptosis in human lung carcinoma A549 cells via mitochondria-mediated death pathway.
Kang TH; Bang JY; Kim MH; Kang IC; Kim HM; Jeong HJ
Food Chem Toxicol; 2011 Feb; 49(2):514-9. PubMed ID: 21130827
[TBL] [Abstract][Full Text] [Related]
48. Enhanced sensitivity to chemotherapy in esophageal cancer through inhibition of NF-kappaB.
Li J; Minnich DJ; Camp ER; Brank A; Mackay SL; Hochwald SN
J Surg Res; 2006 May; 132(1):112-20. PubMed ID: 16337965
[TBL] [Abstract][Full Text] [Related]
49. Synergistic antitumor effect of 5-fluorouracil in combination with parthenolide in human colorectal cancer.
Kim SL; Kim SH; Trang KT; Kim IH; Lee SO; Lee ST; Kim DG; Kang SB; Kim SW
Cancer Lett; 2013 Jul; 335(2):479-86. PubMed ID: 23507557
[TBL] [Abstract][Full Text] [Related]
50. Parthenolide reverses doxorubicin resistance in human lung carcinoma A549 cells by attenuating NF-κB activation and HSP70 up-regulation.
Xin Y; Yin F; Qi S; Shen L; Xu Y; Luo L; Lan L; Yin Z
Toxicol Lett; 2013 Aug; 221(2):73-82. PubMed ID: 23792430
[TBL] [Abstract][Full Text] [Related]
51. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.
Patel NM; Nozaki S; Shortle NH; Bhat-Nakshatri P; Newton TR; Rice S; Gelfanov V; Boswell SH; Goulet RJ; Sledge GW; Nakshatri H
Oncogene; 2000 Aug; 19(36):4159-69. PubMed ID: 10962577
[TBL] [Abstract][Full Text] [Related]
52. Suppressive effects of dehydroepiandrosterone and the nuclear factor-kappaB inhibitor parthenolide on corticotroph tumor cell growth and function in vitro and in vivo.
Taguchi T; Takao T; Iwasaki Y; Nishiyama M; Asaba K; Hashimoto K
J Endocrinol; 2006 Feb; 188(2):321-31. PubMed ID: 16461558
[TBL] [Abstract][Full Text] [Related]
53. Enhancement of chemotherapeutic agent-induced apoptosis by inhibition of NF-kappaB using ursolic acid.
Li Y; Xing D; Chen Q; Chen WR
Int J Cancer; 2010 Jul; 127(2):462-73. PubMed ID: 19908232
[TBL] [Abstract][Full Text] [Related]
54. Combined Parthenolide and Balsalazide Have Enhanced Antitumor Efficacy Through Blockade of NF-κB Activation.
Kim SL; Kim SH; Park YR; Liu YC; Kim EM; Jeong HJ; Kim YN; Seo SY; Kim IH; Lee SO; Lee ST; Kim SW
Mol Cancer Res; 2017 Feb; 15(2):141-151. PubMed ID: 28108625
[TBL] [Abstract][Full Text] [Related]
55. Curcumin-enhanced chemosensitivity of FDA-approved platinum (II)-based anti-cancer drugs involves downregulation of nuclear endonuclease G and NF-κB as well as induction of apoptosis and G2/M arrest.
Wang YT; Liu HS; Su CL
Int J Food Sci Nutr; 2014 May; 65(3):368-74. PubMed ID: 24438326
[TBL] [Abstract][Full Text] [Related]
56. Effect of glutathione combined with cisplatin and oxaliplatin on the proliferation and apoptosis of lung carcinoma cell line.
Xu Y; Jiang N; Yu H
Toxicol Mech Methods; 2010 Oct; 20(8):487-92. PubMed ID: 20843266
[TBL] [Abstract][Full Text] [Related]
57. Anticancer potential of magnolol for lung cancer treatment.
Seo JU; Kim MH; Kim HM; Jeong HJ
Arch Pharm Res; 2011 Apr; 34(4):625-33. PubMed ID: 21544728
[TBL] [Abstract][Full Text] [Related]
58. Atractylenolide II induces G1 cell-cycle arrest and apoptosis in B16 melanoma cells.
Ye Y; Wang H; Chu JH; Chou GX; Chen SB; Mo H; Fong WF; Yu ZL
J Ethnopharmacol; 2011 Jun; 136(1):279-82. PubMed ID: 21524699
[TBL] [Abstract][Full Text] [Related]
59. The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro.
Steele AJ; Jones DT; Ganeshaguru K; Duke VM; Yogashangary BC; North JM; Lowdell MW; Kottaridis PD; Mehta AB; Prentice AG; Hoffbrand AV; Wickremasinghe RG
Leukemia; 2006 Jun; 20(6):1073-9. PubMed ID: 16628188
[TBL] [Abstract][Full Text] [Related]
60. Parthenolide inhibits tumor-promoting effects of nicotine in lung cancer by inducing P53 - dependent apoptosis and inhibiting VEGF expression.
Talib WH; Al Kury LT
Biomed Pharmacother; 2018 Nov; 107():1488-1495. PubMed ID: 30257366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
